Interview focuses on the work of bit.bio and its technology.
06.02.2021Interview focuses on the work of bit.bio and its technology.
Interview focuses on the work of bit.bio and its technology.
06.02.2021Interview focuses on the work of bit.bio and its technology.
bit.bio and the London Institute of Mathematical Sciences (LIMS) want to recreate every human cell type.
13.11.2020bit.bio receives £40m of backing for technology that it claims can reliably reprogram stem cells.
27.10.2020Mark Kotter Bit Bio ideaSpace, focus on a founder, celebrating 10 years of idea space.
25.08.2020The investors behind Bit Bio's series A fundraise.
23.06.2020Bit Bio raises series A funding for its programming approach to human cells.
23.06.2020Discovery Drive-based synthetic biology Bit Bio has closed a $41.5million Series A investment.
16.06.2020Paul Morril, Horizon Discovery co-founder joins as CBO and Florian Schuster, Tessa Therapeutics, as CFO.
29.10.2019bit.bio combines the concepts of coding and biology to provide human cells for research, drug discovery and cell therapy.
14.10.2019